Two Sigma Advisers’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
811,400
+10,800
| +1% | +$15.4K | ﹤0.01% | 1368 |
|
|
2025
Q1 | $1.28M | Sell |
800,600
-83,700
| -9% | -$134K | ﹤0.01% | 1353 |
|
|
2024
Q4 | $3.18M | Sell |
884,300
-181,200
| -17% | -$652K | 0.01% | 902 |
|
|
2024
Q3 | $6.07M | Sell |
1,065,500
-326,400
| -23% | -$1.86M | 0.01% | 646 |
|
|
2024
Q2 | $6.43M | Buy |
1,391,900
+79,700
| +6% | +$368K | 0.01% | 677 |
|
|
2024
Q1 | $10.7M | Buy |
1,312,200
+1,239,500
| +1,705% | +$10.1M | 0.02% | 516 |
|
|
2023
Q4 | $411K | Sell |
72,700
-633,400
| -90% | -$3.58M | ﹤0.01% | 1993 |
|
|
2023
Q3 | $1.31M | Sell |
706,100
-300
| -0% | -$558 | ﹤0.01% | 1411 |
|
|
2023
Q2 | $1.94M | Buy |
706,400
+306,100
| +76% | +$842K | ﹤0.01% | 1215 |
|
|
2023
Q1 | $1.26M | Buy |
400,300
+138,800
| +53% | +$436K | ﹤0.01% | 1515 |
|
|
2022
Q4 | $1.54M | Sell |
261,500
-10,100
| -4% | -$59.6K | ﹤0.01% | 1372 |
|
|
2022
Q3 | $2.38M | Sell |
271,600
-77,900
| -22% | -$683K | 0.01% | 1079 |
|
|
2022
Q2 | $2.64M | Buy |
349,500
+307,300
| +728% | +$2.32M | 0.01% | 1075 |
|
|
2022
Q1 | $1.02M | Buy |
+42,200
| New | +$1.02M | ﹤0.01% | 1626 |
|